This adenovirus reduced the viability of cancer cells and induced immunogenic cell death in vitro, whereas intratumoral injection in combination with an anti-PD-1 antibody in subcutaneous models reduced tumor growth and enhanced tumor-infiltrating CD8+ T cells (61). This evidence concerns the gene CD8A and neoplasm.